Proteomics International Proteomics International, Australian Organizations Launching A$4M Research Facility The partners are developing a new lab that will focus on research into protein biomarkers with medical, agricultural, and environmental applications. Proteomics International, Janssen Collaborating to Evaluate PromarkerD Kidney Disease Test The companies will evaluate the performance of Proteomics International's PromarkerD test for predicting decline in kidney function and drug response. Proteomics International Investing in CPR Pharma Services The proteomics firm is swapping 4 million of its shares for a 10 percent interest in CPR with the goal of moving into clinical trials and related research. Proteomics International to Test Kidney Disease Test as CDx for Investigational Treatment Proteomics International's PromarkerD will be tested in clinical studies alongside Dimerix's investigational chronic kidney disease drug DMX-200. Proteomics International Raises $1.4M The company said it will use the funds to commercialize its proteomic PromarkerD kidney disease test and launch an analytical testing service business. Jun 10, 2015 Initial Validation Done, Proteomics International Seeks Partners on Kidney Disease Test Premium Feb 20, 2015 Proteomics International Labs Delays IPO, Lowers Minimum Target Raise Nov 24, 2014 Australia's Proteomics International Laboratories Launches A$6M IPO Mar 4, 2014 Proteomics International, inVentiv Health Collaborate on Biosimilars Development Aug 2, 2013 People in the News: Kevin Conroy, Katherine Napier, David Thompson, and Roopwant Judge Premium Aug 24, 2012 Proteomics International Wins $1M Grant to Develop Protein Test for Diabetic Nephropathy Premium Aug 21, 2012 Proteomics International Snatches $1M Grant to Develop Kidney Disease Biomarkers for CDx Oct 8, 2010 Proteomics International Developing Protein Biomarker-Based Diagnostic for Diabetic Nephropathy Premium May 24, 2010 Proteomics International Hires 1st Base as Agent in Parts of Asia Aug 24, 2009 Proteomics International Gains ISO Certification Aug 13, 2009 Busselton Health Study Turns to Proteomics to Discover 'Diabesity' Biomarkers Premium Apr 16, 2009 Proteomics International Using Arthropod Venom for New Peptide Drug-Discovery Premium Breaking News In Brief This Week: Illumina, Personalis, Proteomedix, and More Ancient DNA Details Population Dynamics Within Andean Tiwanaku Civilization Genomic Data Spanning 2K Years Gives Glimpse of Etruscan Origins, Population Changes People in the News: New Appointments at Hologic, Akoya Biosciences, Caris Life Sciences, More At NSGC, Genetic Counselors Address Race-Based Medicine, Ways to Change New Products Posted to GenomeWeb: Becton Dickinson, Cosmos-ID, OncoDNA, More The Scan US Booster Eligibility Decision The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions. Arizona Bill Before Judge The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction. Additional Genes Wales is rolling out new genetic testing service for cancer patients, according to BBC News. Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.